Suppr超能文献

瑞士用于自体再生医学的医疗设备:从创新到临床验证。

Swiss Medical Devices for Autologous Regenerative Medicine: From Innovation to Clinical Validation.

作者信息

Gomri Farid, Vischer Solange, Turzi Antoine, Berndt Sarah

机构信息

Regen Lab SA, 1052 Le Mont-sur-Lausanne, Switzerland.

Department of Plastic, Reconstructive and Aesthetic Surgery, Faculty of Medicine, Geneva University Hospitals, 1205 Geneva, Switzerland.

出版信息

Pharmaceutics. 2022 Aug 2;14(8):1617. doi: 10.3390/pharmaceutics14081617.

Abstract

Regenerative medicine, based on the use of autologous tissues and embryonic, stem or differentiated cells, is gaining growing interest. However, their preparation, in a manner compliant with good practices and health regulations, is a technical challenge. The aim of this manuscript is to present the design of reliable CE marked medical devices for the preparation of standardized platelet-rich plasma (PRP) and other autologous biologics intended for therapeutic uses. There are numerous PRP isolation processes. Depending on the methodology used, PRP composition varies greatly in terms of platelet concentration, platelet quality, and level of contamination with red and white blood cells. This variability in PRP composition might affect the clinical outcomes. The devices presented here are based on a specific technology, patented all over the world, that allows the precise separation of blood components as a function of their density using thixotropic separator gels in closed systems. This allows the preparation, in an automated manner, of leukocyte poor PRP with a standardized composition. Production of different forms of PRP is a clinical asset to suit various therapeutic needs. Therefore, we are offering solutions to prepare PRP either in liquid or gel form, and PRP combined with hyaluronic acid. These biologics have been successfully used in many different therapeutic domains, resulting in more than 150 published clinical studies. We also developed the CuteCell technology platform for cell culture expansion for further autologous cell therapies. This technology enables the safe and rapid in vitro expansion of cells intended for therapeutic use in good manufacturing practices (GMP) and autologous conditions, using blood-derived products as culture media supplementation. We summarize in this article our 20 years' experience of research and development for the design of PRP devices and, more recently, for PRP combined with hyaluronic acid.

摘要

基于自体组织以及胚胎、干细胞或分化细胞的再生医学正越来越受到关注。然而,以符合良好操作规范和健康法规的方式制备这些组织和细胞是一项技术挑战。本手稿的目的是介绍用于制备标准化富血小板血浆(PRP)和其他用于治疗用途的自体生物制品的可靠的CE标志医疗设备的设计。有许多PRP分离方法。根据所使用的方法,PRP的组成在血小板浓度、血小板质量以及红细胞和白细胞的污染水平方面有很大差异。PRP组成的这种变异性可能会影响临床结果。这里介绍的设备基于一项在全球获得专利的特定技术,该技术允许在封闭系统中使用触变分离凝胶根据血液成分的密度精确分离血液成分。这使得能够以自动化方式制备具有标准化组成的低白细胞PRP。生产不同形式的PRP是满足各种治疗需求的一项临床优势。因此,我们提供制备液体或凝胶形式的PRP以及PRP与透明质酸组合的解决方案。这些生物制品已成功用于许多不同的治疗领域,已有超过150项发表的临床研究。我们还开发了用于细胞培养扩增的CuteCell技术平台,以用于进一步的自体细胞治疗。该技术能够在良好生产规范(GMP)和自体条件下,使用血液衍生产品作为培养基补充剂,安全、快速地体外扩增用于治疗的细胞。在本文中,我们总结了我们在设计PRP设备以及最近在设计PRP与透明质酸组合方面20年的研发经验。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e7b/9413293/42f492238f37/pharmaceutics-14-01617-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验